178 related articles for article (PubMed ID: 19112017)
1. Selection and characterization of a human monoclonal neutralizing antibody for Clostridium Botulinum neurotoxin serotype B.
Zhou H; Zhou B; Pellett S; Johnson EA; Janda KD
Bioorg Med Chem Lett; 2009 Feb; 19(3):662-4. PubMed ID: 19112017
[TBL] [Abstract][Full Text] [Related]
2. Immunological Characterization and Neutralizing Ability of Monoclonal Antibodies Directed Against Botulinum Neurotoxin Type H.
Fan Y; Barash JR; Lou J; Conrad F; Marks JD; Arnon SS
J Infect Dis; 2016 May; 213(10):1606-14. PubMed ID: 26936913
[TBL] [Abstract][Full Text] [Related]
3. Fully Human Monoclonal Antibodies Effectively Neutralizing Botulinum Neurotoxin Serotype B.
Matsumura T; Amatsu S; Misaki R; Yutani M; Du A; Kohda T; Fujiyama K; Ikuta K; Fujinaga Y
Toxins (Basel); 2020 May; 12(5):. PubMed ID: 32392791
[TBL] [Abstract][Full Text] [Related]
4. Extraction and inhibition of enzymatic activity of botulinum neurotoxins /B1, /B2, /B3, /B4, and /B5 by a panel of monoclonal anti-BoNT/B antibodies.
Kalb SR; Santana WI; Geren IN; Garcia-Rodriguez C; Lou J; Smith TJ; Marks JD; Smith LA; Pirkle JL; Barr JR
BMC Biochem; 2011 Nov; 12():58. PubMed ID: 22085466
[TBL] [Abstract][Full Text] [Related]
5. In-Vivo Neutralization of Botulinum Neurotoxin Serotype E Using Rabbit Polyclonal Antibody Developed against BoNT/E Light Chain.
Rani S; Ponmariappan S; Sharma A; Kamboj DV; Jain AK
Protein Pept Lett; 2017; 24(6):495-502. PubMed ID: 28260503
[TBL] [Abstract][Full Text] [Related]
6. Neutralization of Botulinum Neurotoxin Type E by a Humanized Antibody.
Derman Y; Selby K; Miethe S; Frenzel A; Liu Y; Rasetti-Escargueil C; Avril A; Pelat T; Urbain R; Fontayne A; Thullier P; Sesardic D; Lindström M; Hust M; Korkeala H
Toxins (Basel); 2016 Sep; 8(9):. PubMed ID: 27626446
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a novel tetravalent botulism antitoxin based on receptor-binding domain of BoNTs.
Shi DY; Lu JS; Mao YY; Liu FJ; Wang R; Du P; Yu S; Yu YZ; Yang ZX
Appl Microbiol Biotechnol; 2023 May; 107(10):3205-3216. PubMed ID: 37058230
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of a neutralizing antibody specific to internalization domain of Clostridium botulinum neurotoxin type B.
Yang GH; Kim KS; Kim HW; Jeong ST; Huh GH; Kim JC; Jung HH
Toxicon; 2004 Jul; 44(1):19-25. PubMed ID: 15225558
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing Concentrations of Anti-Botulinum Toxin Antibodies Positively Correlate with Mouse Neutralization Assay Results in a Guinea Pig Model.
Tomic MT; Farr-Jones S; Syar ES; Niemuth N; Kobs D; Hackett MJ; Espinoza Y; Martinez Z; Pham K; Snow DM; Marks JD; Cobb RR
Toxins (Basel); 2021 Sep; 13(9):. PubMed ID: 34564675
[TBL] [Abstract][Full Text] [Related]
10. Development of Germline-Humanized Antibodies Neutralizing Botulinum Neurotoxin A and B.
Miethe S; Mazuet C; Liu Y; Tierney R; Rasetti-Escargueil C; Avril A; Frenzel A; Thullier P; Pelat T; Urbain R; Fontayne A; Sesardic D; Hust M; Popoff MR
PLoS One; 2016; 11(8):e0161446. PubMed ID: 27560688
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of Hc-targeting chimeric heavy chain antibodies neutralizing botulinum neurotoxin type B.
Jiang Y; Wang R; Guo J; Cheng K; Chen L; Wang X; Li Y; Du P; Gao C; Lu J; Yu Y; Yang Z
Front Immunol; 2024; 15():1380694. PubMed ID: 38779676
[TBL] [Abstract][Full Text] [Related]
12. Production of a neutralizing mouse-human chimeric antibody against botulinum neurotoxin serotype E.
Mukamoto M; Maeda H; Kohda T; Nozaki C; Takahashi M; Kozaki S
Jpn J Infect Dis; 2013; 66(1):46-50. PubMed ID: 23429085
[TBL] [Abstract][Full Text] [Related]
13. Development of human-like scFv-Fc antibodies neutralizing Botulinum toxin serotype B.
Rasetti-Escargueil C; Avril A; Chahboun S; Tierney R; Bak N; Miethe S; Mazuet C; Popoff MR; Thullier P; Hust M; Pelat T; Sesardic D
MAbs; 2015; 7(6):1161-77. PubMed ID: 26381852
[TBL] [Abstract][Full Text] [Related]
14. Fine and domain-level epitope mapping of botulinum neurotoxin type A neutralizing antibodies by yeast surface display.
Levy R; Forsyth CM; LaPorte SL; Geren IN; Smith LA; Marks JD
J Mol Biol; 2007 Jan; 365(1):196-210. PubMed ID: 17059824
[TBL] [Abstract][Full Text] [Related]
15. Development of neutralizing scFv-Fc against botulinum neurotoxin A light chain from a macaque immune library.
Miethe S; Rasetti-Escargueil C; Liu Y; Chahboun S; Pelat T; Avril A; Frenzel A; Schirrmann T; Thullier P; Sesardic D; Hust M
MAbs; 2014; 6(2):446-59. PubMed ID: 24492304
[TBL] [Abstract][Full Text] [Related]
16. A three monoclonal antibody combination potently neutralizes multiple botulinum neurotoxin serotype F subtypes.
Fan Y; Garcia-Rodriguez C; Lou J; Wen W; Conrad F; Zhai W; Smith TJ; Smith LA; Marks JD
PLoS One; 2017; 12(3):e0174187. PubMed ID: 28323873
[TBL] [Abstract][Full Text] [Related]
17. High level expression and immunochemical characterization of botulinum neurotoxin type F light chain.
Chauhan R; Chauhan V; Rao MK; Chaudhary D; Bhagyawant S; Dhaked RK
Protein Expr Purif; 2018 Jun; 146():51-60. PubMed ID: 29407166
[TBL] [Abstract][Full Text] [Related]
18. Improved detection methods by genetic and immunological techniques for botulinum C/D and D/C mosaic neurotoxins.
Nakamura K; Kohda T; Seto Y; Mukamoto M; Kozaki S
Vet Microbiol; 2013 Mar; 162(2-4):881-890. PubMed ID: 23206412
[TBL] [Abstract][Full Text] [Related]
19. Development of Human-Like scFv-Fc Neutralizing Botulinum Neurotoxin E.
Miethe S; Rasetti-Escargueil C; Avril A; Liu Y; Chahboun S; Korkeala H; Mazuet C; Popoff MR; Pelat T; Thullier P; Sesardic D; Hust M
PLoS One; 2015; 10(10):e0139905. PubMed ID: 26440796
[TBL] [Abstract][Full Text] [Related]
20. A novel strain of Clostridium botulinum that produces type B and type H botulinum toxins.
Barash JR; Arnon SS
J Infect Dis; 2014 Jan; 209(2):183-91. PubMed ID: 24106296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
